DE60203042D1 - Neue phenylpiperazine - Google Patents

Neue phenylpiperazine

Info

Publication number
DE60203042D1
DE60203042D1 DE60203042T DE60203042T DE60203042D1 DE 60203042 D1 DE60203042 D1 DE 60203042D1 DE 60203042 T DE60203042 T DE 60203042T DE 60203042 T DE60203042 T DE 60203042T DE 60203042 D1 DE60203042 D1 DE 60203042D1
Authority
DE
Germany
Prior art keywords
phenyl piperazine
new phenyl
new
piperazine
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60203042T
Other languages
English (en)
Other versions
DE60203042T2 (de
Inventor
W Feenstra
Eric Ronken
G Kruse
C Mccreary
Scharrenburg J Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Healthcare Products BV
Original Assignee
Solvay Pharmaceuticals BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals BV filed Critical Solvay Pharmaceuticals BV
Publication of DE60203042D1 publication Critical patent/DE60203042D1/de
Application granted granted Critical
Publication of DE60203042T2 publication Critical patent/DE60203042T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60203042T 2001-02-21 2002-02-19 Neue Phenylciperazine Expired - Lifetime DE60203042T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01200609 2001-02-21
EP01200609 2001-02-21
PCT/EP2002/001793 WO2002066472A1 (en) 2001-02-21 2002-02-19 New phenylpiperazines

Publications (2)

Publication Number Publication Date
DE60203042D1 true DE60203042D1 (de) 2005-03-31
DE60203042T2 DE60203042T2 (de) 2006-01-19

Family

ID=8179908

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60203042T Expired - Lifetime DE60203042T2 (de) 2001-02-21 2002-02-19 Neue Phenylciperazine

Country Status (29)

Country Link
US (1) US6828325B2 (de)
EP (1) EP1395583B1 (de)
JP (1) JP4178033B2 (de)
KR (1) KR100848482B1 (de)
CN (1) CN1190433C (de)
AR (1) AR032711A1 (de)
AT (1) ATE289604T1 (de)
AU (1) AU2002253043B2 (de)
BR (1) BR0205220A (de)
CA (1) CA2411973A1 (de)
CZ (1) CZ299487B6 (de)
DE (1) DE60203042T2 (de)
DK (1) DK1395583T3 (de)
DZ (1) DZ3441A1 (de)
ES (1) ES2235029T3 (de)
HK (1) HK1059781A1 (de)
HU (1) HUP0303329A3 (de)
IL (1) IL153176A (de)
MX (1) MXPA03004242A (de)
NO (1) NO323781B1 (de)
NZ (1) NZ523135A (de)
PL (1) PL359650A1 (de)
PT (1) PT1395583E (de)
RU (1) RU2279431C2 (de)
SI (1) SI1395583T1 (de)
SK (1) SK286064B6 (de)
UA (1) UA74426C2 (de)
WO (1) WO2002066472A1 (de)
ZA (1) ZA200209897B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL201178B1 (pl) 1999-08-23 2009-03-31 Solvay Pharm Bv Nowe pochodne fenylopiperazyny, sposób ich wytwarzania, kompozycja farmaceutyczna oraz zastosowanie
AR032712A1 (es) 2001-02-21 2003-11-19 Solvay Pharm Bv Un mesilato de derivados de fenilpiperazina y composiciones farmaceuticas que lo contienen
CA2453837C (en) * 2001-07-20 2011-10-04 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder using eltoprazine and related compounds
EP1683790A1 (de) * 2005-01-24 2006-07-26 Institut National De La Sante Et De La Recherche Medicale (Inserm) 3,4-Dihydro-2-Naphthamidderivate als selektive Dopamin-D3-Liganden
GB0708818D0 (en) * 2007-05-08 2007-06-13 Portela & Ca Sa Compounds
WO2011082266A2 (en) 2009-12-30 2011-07-07 Arqule, Inc. Substituted heterocyclic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0900792B1 (de) * 1997-09-02 2003-10-29 Duphar International Research B.V Piperidin- und Piperazin Derivate als 5-HT1-Rezeptor-Agonisten
CA2335711A1 (en) * 1998-06-19 1999-12-29 Ivan Mikkelsen 4,5,6 and 7-indole and indoline derivatives, their preparation and use
AR020773A1 (es) * 1998-10-16 2002-05-29 Duphar Int Res Compuesto derivados de 3-(tetrahidropiridin-4-il)indol, metodo para prepararlo, una composicion farmaceutica que los contiene, metodo para preparar dicha composicion y uso del compuesto
PL201178B1 (pl) 1999-08-23 2009-03-31 Solvay Pharm Bv Nowe pochodne fenylopiperazyny, sposób ich wytwarzania, kompozycja farmaceutyczna oraz zastosowanie
EP1336406A1 (de) 2002-02-14 2003-08-20 Solvay Pharmaceuticals B.V. Partieller Dopamin-D2 Rezeptoragonist plus Substanzen mit Serotonin- und/oder Noradrenalin inhibitorischer Aktivität

Also Published As

Publication number Publication date
JP4178033B2 (ja) 2008-11-12
SK18052002A3 (sk) 2003-05-02
DZ3441A1 (fr) 2002-08-29
CA2411973A1 (en) 2002-08-29
PT1395583E (pt) 2005-06-30
CZ20023933A3 (cs) 2003-03-12
JP2004518746A (ja) 2004-06-24
UA74426C2 (uk) 2005-12-15
EP1395583A1 (de) 2004-03-10
AU2002253043B2 (en) 2006-06-08
HK1059781A1 (en) 2004-07-16
SI1395583T1 (de) 2005-08-31
KR100848482B1 (ko) 2008-07-28
DK1395583T3 (da) 2005-03-29
DE60203042T2 (de) 2006-01-19
ATE289604T1 (de) 2005-03-15
IL153176A0 (en) 2003-06-24
US20030162791A1 (en) 2003-08-28
US6828325B2 (en) 2004-12-07
ZA200209897B (en) 2004-03-05
AR032711A1 (es) 2003-11-19
KR20030072215A (ko) 2003-09-13
MXPA03004242A (es) 2003-09-22
WO2002066472A1 (en) 2002-08-29
CZ299487B6 (cs) 2008-08-13
NZ523135A (en) 2005-02-25
EP1395583B1 (de) 2005-02-23
NO20025902D0 (no) 2002-12-09
PL359650A1 (en) 2004-08-23
CN1463269A (zh) 2003-12-24
HUP0303329A3 (en) 2008-12-29
NO323781B1 (no) 2007-07-02
IL153176A (en) 2012-10-31
ES2235029T3 (es) 2005-07-01
RU2279431C2 (ru) 2006-07-10
CN1190433C (zh) 2005-02-23
HUP0303329A2 (hu) 2004-01-28
SK286064B6 (sk) 2008-02-05
BR0205220A (pt) 2003-06-24
NO20025902L (no) 2002-12-09

Similar Documents

Publication Publication Date Title
DK1325008T3 (da) Piperazinderivater
NO20043079L (no) Piperazinderivat
IS6971A (is) Ný efnasambönd
DE50210090D1 (de) Substituierte phenylderivate
IS6546A (is) Nýjar píperazín afleiður
DK1472255T3 (da) Aza-arylpiperaziner
DE60202489D1 (de) Lysin enthaltende kautablette
FI20011507A0 (fi) Uusia yhdisteitä
NO20023954D0 (no) Substituerte piperasinforbindelser
DE60203042D1 (de) Neue phenylpiperazine
DE50202134D1 (de) Drosselklappenanordnung
ATE292108T1 (de) Neue phenyl-propargylether derivate
FR2819882B1 (fr) Cartouche
DE50309081D1 (de) Neue diketopyrrolopyrrolpigmente
DE60206043D1 (de) Neue indolderivate
FR2824818B1 (fr) Pot rectangulaire
DE60233952D1 (de) Neue serinprotease
SE0103728D0 (sv) New polypeptides II
SE0101958D0 (sv) New compounds
SE0100629D0 (sv) New compounds
SE0104366D0 (sv) New compounds
SE0101660D0 (sv) New compounds
SE0101659D0 (sv) New compounds
SE0102056D0 (sv) New Compounds
SE0102386D0 (sv) New compounds

Legal Events

Date Code Title Description
8364 No opposition during term of opposition